B

Beta Bionics Inc
NASDAQ:BBNX

Watchlist Manager
Beta Bionics Inc
NASDAQ:BBNX
Watchlist
Price: 14.43 USD -6.96% Market Closed
Market Cap: 625.5m USD

Intrinsic Value

BBNX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one BBNX stock under the Base Case scenario is 11.46 USD. Compared to the current market price of 14.43 USD, Beta Bionics Inc is Overvalued by 21%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BBNX Intrinsic Value
11.46 USD
Overvaluation 21%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation History
Beta Bionics Inc

Valuation History Unavailable

Historical valuation for BBNX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Beta Bionics Inc
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Beta Bionics Inc

Balance Sheet Decomposition
Beta Bionics Inc

Current Assets 132.9m
Cash & Short-Term Investments 103.6m
Receivables 12m
Other Current Assets 17.4m
Non-Current Assets 16.7m
PP&E 11.4m
Other Non-Current Assets 5.3m
Efficiency

Free Cash Flow Analysis
Beta Bionics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Beta Bionics Inc

Revenue
65.1m USD
Cost of Revenue
-29.2m USD
Gross Profit
35.9m USD
Operating Expenses
-81.1m USD
Operating Income
-45.3m USD
Other Expenses
-9.5m USD
Net Income
-54.8m USD
Fundamental Scores

BBNX Profitability Score
Profitability Due Diligence

Beta Bionics Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Positive Gross Profit
Exceptional 1-Year Revenue Growth
Negative Operating Income
26/100
Profitability
Score

Beta Bionics Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

BBNX Solvency Score
Solvency Due Diligence

Beta Bionics Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
56/100
Solvency
Score

Beta Bionics Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BBNX Price Targets Summary
Beta Bionics Inc

Wall Street analysts forecast BBNX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BBNX is 26.23 USD with a low forecast of 18.18 USD and a high forecast of 31.5 USD.

Lowest
Price Target
18.18 USD
26% Upside
Average
Price Target
26.23 USD
82% Upside
Highest
Price Target
31.5 USD
118% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Beta Bionics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for BBNX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one BBNX stock?

The intrinsic value of one BBNX stock under the Base Case scenario is 11.46 USD.

Is BBNX stock undervalued or overvalued?

Compared to the current market price of 14.43 USD, Beta Bionics Inc is Overvalued by 21%.

Back to Top